Zhou JG

ORCID: 0000-0002-5021-3739 · 2 papers in corpus

2025

Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma.

Technology in cancer research & treatment ·doi:10.1177/15330338251343487

IntroductionUterine sarcoma (US) is a rare tumor characterized by high aggressiveness, a tendency for recurrence and distant metastasis, and an extremely poor prognosis. In this study, we evaluated the expression of Orosomucoid 1 (ORM1) in …

2024

Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.

Technology in cancer research & treatment ·doi:10.1177/15330338241245924

BackgroundUterine sarcoma (US) is a highly malignant cancer with poor prognosis and high mortality in women. In this study, we evaluated the expression of human fibroblast growth factor 23 (FGF23) in different US subtypes and the relationsh…